Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 13,820.00p on 21-11-2025 at 19:40:05
Change 170.00p 1.25%
Buy 13,838.00p
Sell 13,832.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 45.00 at 13,652.18713p
Day's Volume: 3,044,642
Last Close: 13,820.00p
Open: 13,508.00p
ISIN: GB0009895292
Day's Range 13,508.00p - 13,836.00p
52wk Range: 9,574.00p - 13,884.00p
Market Capitalisation: £214.25b
VWAP: 13,663.67057p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 45 13,652.18713p Currency Conversion
Negotiated Trade
OTC Trade
 17:33:02 - 21-Nov-25
Unknown* 147 13,656.12774p Currency Conversion
Negotiated Trade
OTC Trade
 17:32:49 - 21-Nov-25
Sell* 80 13,820.00p SI Trade
Suspected SELL Trade
 16:49:35 - 21-Nov-25
Sell* 1,083 13,820.00p Negotiated Trade
 16:37:44 - 21-Nov-25
Sell* 13 13,820.00p Automatic Execution
 16:36:12 - 21-Nov-25
Buy* 429 13,820.00p SI Trade
 16:35:08 - 21-Nov-25
Buy* 820 13,820.00p SI Trade
 16:35:08 - 21-Nov-25
Buy* 1 13,820.00p SI Trade
 16:35:08 - 21-Nov-25
Buy* 41 13,820.00p SI Trade
 16:35:08 - 21-Nov-25
Buy* 17 13,820.00p SI Trade
 16:35:08 - 21-Nov-25
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
21st Nov 2025 (Fri) 13,508.00 13,836.00 13,508.00 13,820.00 3,044,642
20th Nov 2025 (Thu) 13,604.00 13,788.00 13,600.00 13,650.00 1,656,417
19th Nov 2025 (Wed) 13,560.00 13,742.00 13,506.00 13,596.00 1,594,092
18th Nov 2025 (Tue) 13,800.00 13,884.00 13,466.00 13,566.00 1,654,390
17th Nov 2025 (Mon) 13,530.00 13,658.00 13,520.00 13,592.00 1,324,376
14th Nov 2025 (Fri) 13,464.00 13,574.00 13,408.00 13,532.00 1,347,776
13th Nov 2025 (Thu) 13,440.00 13,506.00 13,320.00 13,494.00 1,534,952
12th Nov 2025 (Wed) 13,548.00 13,548.00 13,390.00 13,518.00 1,841,563
11th Nov 2025 (Tue) 13,400.00 13,508.00 13,286.00 13,466.00 2,222,864
10th Nov 2025 (Mon) 12,904.00 13,206.00 12,840.00 13,126.00 3,313,114
7th Nov 2025 (Fri) 12,788.00 12,938.00 12,714.00 12,900.00 3,536,318
6th Nov 2025 (Thu) 12,570.00 12,994.00 12,330.00 12,834.00 3,100,521
5th Nov 2025 (Wed) 12,528.00 12,596.00 12,436.00 12,450.00 1,818,390
4th Nov 2025 (Tue) 12,448.00 12,528.00 12,242.00 12,528.00 1,233,294
3rd Nov 2025 (Mon) 12,546.00 12,584.00 12,352.00 12,364.00 1,847,968
31st Oct 2025 (Fri) 12,562.00 12,584.00 12,424.00 12,470.00 1,088,828
30th Oct 2025 (Thu) 12,456.00 12,556.00 12,366.00 12,546.00 1,214,406
29th Oct 2025 (Wed) 12,500.00 12,684.00 12,424.00 12,560.00 946,472
28th Oct 2025 (Tue) 12,586.00 12,708.00 12,406.00 12,406.00 1,501,103
27th Oct 2025 (Mon) 12,530.00 12,616.00 12,446.00 12,546.00 1,464,674
24th Oct 2025 (Fri) 12,530.00 12,582.00 12,418.00 12,532.00 1,528,688
23rd Oct 2025 (Thu) 12,432.00 12,566.00 12,432.00 12,496.00 1,297,487
22nd Oct 2025 (Wed) 12,398.00 12,628.00 12,382.00 12,540.00 4,968,617
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
20th Nov 2025 7:00 am RNS Koselugo (selumetinib) approved in the US
17th Nov 2025 3:00 pm RNS Holding(s) in Company
14th Nov 2025 11:00 am RNS Director/PDMR Shareholding
10th Nov 2025 3:00 pm RNS Director/PDMR Shareholding
6th Nov 2025 7:00 am RNS 9M and Q3 2025 results
3rd Nov 2025 4:00 pm RNS Result of General Meeting
3rd Nov 2025 3:00 pm RNS Total Voting Rights
28th Oct 2025 7:05 am RNS Director Declaration
28th Oct 2025 7:00 am RNS Koselugo (selumetinib) approved in the EU
22nd Oct 2025 7:00 am RNS Tezspire Approved in EU for CRSwNP
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca unveils USD2 billion manufacturing investment in Maryland

21st Nov 2025 21:59

(Alliance News) - AstraZeneca PLC on Friday announced plans to invest USD2 billion to expand its long-standing manufacturing footprint in Maryland. Read More

AstraZeneca gets US approval for Koselugo for rare genetic disorder

20th Nov 2025 09:06

(Alliance News) - AstraZeneca PLC on Thursday said US regulators have approved its drug Koselugo for use in adults with neurofibromatosis type 1, expanding access to a treatment already used in children with the rare genetic condition. Read More

LONDON MARKET OPEN: Stocks sold off on lingering tech worry

18th Nov 2025 08:45

(Alliance News) - Stock prices in Europe opened in the red on Tuesday, following sharp falls in Asia and as equities in New York struggled overnight, with the S&P 500 ending below a key level for the first time a number of months. Read More

LONDON MARKET CLOSE: Stocks hit, bond yields jump amid tax U-turn talk

14th Nov 2025 17:03

(Alliance News) - Stocks fell and bonds yields spiked in volatile trading on Friday amid uncertainty over UK budget proposals after an apparent u-turn on tax policy by Chancellor Rachel Reeves. Read More

DIRECTOR DEALINGS: Springfield Properties chair banks GBP2.6 million

14th Nov 2025 11:21

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News: Read More

See more Astrazeneca news
FTSE 100 Latest
Value9,539.71
Change12.06

Login to your account

Forgot Password?

Not Registered